We Think You Can Look Beyond C.E.Management Integrated LaboratoryLtd's (TSE:6171) Lackluster Earnings

Soft earnings didn't appear to concern C.E.Management Integrated Laboratory Co.Ltd's (TSE:6171) shareholders over the last week. We think that the softer headline numbers might be getting counterbalanced by some positive underlying factors.

See our latest analysis for C.E.Management Integrated LaboratoryLtd

Zooming In On C.E.Management Integrated LaboratoryLtd's Earnings

In high finance, the key ratio used to measure how well a company converts reported profits into free cash flow (FCF) is the accrual ratio (from cashflow). To get the accrual ratio we first subtract FCF from profit for a period, and then divide that number by the average operating assets for the period. This ratio tells us how much of a company's profit is not backed by free cashflow.

That means a negative accrual ratio is a good thing, because it shows that the company is bringing in more free cash flow than its profit would suggest. While it's not a problem to have a positive accrual ratio, indicating a certain level of non-cash profits, a high accrual ratio is arguably a bad thing, because it indicates paper profits are not matched by cash flow. To quote a 2014 paper by Lewellen and Resutek, "firms with higher accruals tend to be less profitable in the future".

Over the twelve months to December 2023, C.E.Management Integrated LaboratoryLtd recorded an accrual ratio of -0.20. Therefore, its statutory earnings were very significantly less than its free cashflow. Indeed, in the last twelve months it reported free cash flow of JP¥900m, well over the JP¥190.0m it reported in profit. C.E.Management Integrated LaboratoryLtd's free cash flow improved over the last year, which is generally good to see. Having said that, there is more to the story. The accrual ratio is reflecting the impact of unusual items on statutory profit, at least in part.

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of C.E.Management Integrated LaboratoryLtd.

The Impact Of Unusual Items On Profit

C.E.Management Integrated LaboratoryLtd's profit was reduced by unusual items worth JP¥113m in the last twelve months, and this helped it produce high cash conversion, as reflected by its unusual items. In a scenario where those unusual items included non-cash charges, we'd expect to see a strong accrual ratio, which is exactly what has happened in this case. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that's hardly a surprise given these line items are considered unusual. Assuming those unusual expenses don't come up again, we'd therefore expect C.E.Management Integrated LaboratoryLtd to produce a higher profit next year, all else being equal.

Our Take On C.E.Management Integrated LaboratoryLtd's Profit Performance

Considering both C.E.Management Integrated LaboratoryLtd's accrual ratio and its unusual items, we think its statutory earnings are unlikely to exaggerate the company's underlying earnings power. After considering all this, we reckon C.E.Management Integrated LaboratoryLtd's statutory profit probably understates its earnings potential! If you'd like to know more about C.E.Management Integrated LaboratoryLtd as a business, it's important to be aware of any risks it's facing. Case in point: We've spotted 5 warning signs for C.E.Management Integrated LaboratoryLtd you should be mindful of and 1 of them can't be ignored.

After our examination into the nature of C.E.Management Integrated LaboratoryLtd's profit, we've come away optimistic for the company. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.